Analysed Upstream Bio Inc (UPB:NASDAQ) News Sources
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Yahoo Finance
DelveInsight Business Research, LLP: Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced ...
FinanzNachrichten.de
Investigational Monoclonal Antibody Verekitug Improved Symptoms of Chronic Rhinosinusitis With Nasal Polyps
Medscape
Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight
PR Newswire UK
Nuvation Bio Inc. (NUVB) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Seeking Alpha
Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit
Yahoo Finance Canada
What is the current price of Upstream Bio Inc (UPB:NASDAQ)?
The current price of Upstream Bio Inc (UPB:NASDAQ) is $7.66.
Upstream Bio Inc (UPB:NASDAQ) absolute price change since previous trading day?
The absolute price change of Upstream Bio Inc (UPB:NASDAQ) since the previous trading day is $-0.01.
Upstream Bio Inc (UPB:NASDAQ) percentage price change since previous trading day?
The percentage price change of Upstream Bio Inc (UPB:NASDAQ) since the previous trading day is -0.13%.
What is This Week's average sentiment score for Upstream Bio Inc (UPB:NASDAQ)?
This Week's average sentiment score for Upstream Bio Inc (UPB:NASDAQ) is 70 out of 100.
What is This Week's average sentiment for Upstream Bio Inc (UPB:NASDAQ)?
This Week's sentiment for Upstream Bio Inc (UPB:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.